CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.

Slides:



Advertisements
Similar presentations
Synucleinopathies and Tauopathies
Advertisements

Demyelinating Diseases. Demyelination is a common degenerative change in the nervous system secondary to neuronal or axonal injury, But in the group of.
Parkinson’s Cognitive Problems versus Other Neurological Diseases 14 February 2015 Carole A. Mazurowski, PhD Health Psychology & Neuropsychology 6565 Americas.
Results All neuropathologies were associated with clinical dementia when controlling for cortical plaques and tangles except Hirano bodies, GVD and brainstem.
Johns Hopkins University School of Medicine Clinico-Pathological Conference Benjamin M. Greenberg, M.D., M.H.S. Assistant Professor Department of Neurology.
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
CN-1 Neuropathology of Parkinson’s Disease Dementia James B. Leverenz, MD Associate Professor Neurology and Psychiatry and Behavioral Sciences University.
Dementia with Lewy Bodies
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
PSYC D Dementias 1 Dementias. Dementias 2 Neurodegenerative Disorders A varied assortment of central nervous system disorders characterized by.
A 67-year-old male with behavioral and language problems
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Pearls and Pitfalls of I-123 Ioflupane (DaTscan) SPECT Imaging: What the Radiologist and Clinician Need to Know Ammar A Chaudhry, MD, Maryam Gul, MD,
Degenerative brain disease The term “Degenerative”: – an underlying cellular degeneration of neurons in the brain Cause symptoms that depend on the pattern.
Introduction to Degenerative Brain Diseases
Non-Alzheimer’s Dementias
Parkinson’s Plus By: Glen Estrosos.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Imaging Degenerative Diseases of the Brain Cathleen Kouvolo.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
American Association of Neuropathologists: 2011 Diagnostic Slide Session Jeremy Deisch, M.D. Dennis Burns, M.D. Charles White III, M.D.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
2010 MEETING, PHILADELPHIA AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS DSS CASE # 11 J-M BILBAO, B YOUNG and N LIU SUNNYBROOK HOSPITAL UNIVERSITY OF TORONTO.
Alzheimer’s Disease. Alzheimer's is a the most common form of dementia. Nearly 50-80% of all dementia patients have Alzheimer's. It is a progressive fatal.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
Diagnostic Slide Session Mark Samols 1, Kari-Elise Codispoti 1, Marc Rosenblum 2, Barbara Crain 1 1 Johns Hopkins Hospital, Baltimore MD 2 Memorial.
D E M E N T I A Q: What other types of dementia are there? Q: What other types of dementia are there? Q: Do they have the same pathophysiology as Alzeimer.
Focal Syndromes Dr Stephen Pearson Consultant in Old Age Psychiatry Devon Partnership Trust.
Gross Anatomy and CNS Organization; Neuroimaging Techniques March 31, 2011.
Dementia Nicholas Cascone, PA-C.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Pathologic features of AD. Pathologic changes (specifically plaques, tangles, and the associated neuronal loss and glial reaction) a. Are evident first.
Neurodegenerative Diseases
Pathogenesis and pathology of parkinsonism
Introduction to Degenerative Dementing Diseases Diagnosis & Management Issues. Marilee Monnot, Ph.D., Assistant Professor Department of Neurology, College.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Evidence of Multisystem Disorder in Whole-Brain Map.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Path: Nongenetic Degenerative Disorders Chris Pierson, MD, PhD Neuropathologist, Nationwide Children’s Hospital Associate Professor of Pathology
Frontotemporal Lobar Degeneration:
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Absence of β-Amyloid Deposits After Immunization in.
Demence - poznámky o diagnostice a léčbě (IChE, nootropika, fytoterapeutika -EGb ) Loss of hippocampal volumes and memory impairment are typical findings.
RB Clincopathologic Conference (CPC) 3/18/2016 Thomas Shoemaker, MD Ronald Hamilton, MD.
Neurodegenerative Neuropath. The Neurodegenerates  Alzheimer’s Disease  Parkinson’s Disease  Lewy Body Dementia  Multiple Systems Atrophy  FTD /
Dementia with Lewy Bodies
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
FRONTOTEMPORAL DEMENTIA IN A CASE OF SUICIDAL HANGING
Frontotemporal dementia syndromes are united by underlying frontotemporal lobar degeneration pathology, which can be divided according to the presence.
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Small section of the neocortex from a patient with Alzheimer disease showing two classical neuropathologic lesions of the disease. A. The modified silver.
The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report  Carolin A.M. Koriath,
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Atypical Parkinsonian Syndromes
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Psychiatric and Related Disorders
Volume 91, Issue 1, Pages (July 2016)
Michel Goedert, Florence Clavaguera, Markus Tolnay 
NEURODEGENERATIVE DISEASES
Transmissible human proteopathies: an expanding field
CNS.
Introduction to degenerative brain disease
Presentation transcript:

CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009

Gross brain findings Lacunar infarct, left putamenNO hippocampal atrophy Well pigmented substantia nigra

No evidence of Alzheimer disease No neuritic plaquesFrequent neurofibrillary tangles in hippocampus (above) and entorhinal cortex; sparse tangles in temporal cortex Silver

Evidence of Parkinson disease?  Lewy bodies in brainstem or cortex?  α-synuclein stains? ?

Evidence of Parkinson disease? NO  Lewy bodies in brainstem or cortex? NO  α-synuclein stains? Negative

Globose tangles (cytoplasmic inclusions) in neurons of substantia nigra Globose tangles displacing neuromelaninTau-positive H&ETau

Similar tangles in multiple brainstem and deep gray areas Base of ponsGlobus pallidus

Tau-positive inclusions in glia Thorn-shaped astrocyte Smaller inclusions in astrocytes and oligos Tufted astrocytes

Frontal and temporal neocortex Spongiosis in outer layers of cortex Occasional astrocytic plaques TauH&E

“TAUOPATHY”: Progressive supranuclear palsy (PSP  High density of tangles and threads in at least 3: -Substantia nigra -Basis pontis -Globus pallidus -Subthalamic nucleus  Low to high density of tangles or threads in at least 3: -Striatum -Oculomotor complex -Medulla -Dentate nucleus AND

Progressive supranuclear palsy (PSP)  Classic syndrome -Akinetic / rigid parkinsonism and falls -Tremors mild or absent -Symptoms poorly responsive to L-DOPA -Supranuclear gaze palsy, particularly vertical -Cognitive change, dementia late if at all  More recently -Dementia (FTD-type) can predominate (behavioral and/or language problems) -Not all patients have eye findings  Gross brain changes -Pallor of substantia nigra -Brainstem atrophy -Variable cortical atrophy Dudley Moore

“Protein-based” classification system: Ubiquitin-positive Tau-negative (most TDP-43+)  FTLD-U  FTLD-U / MND (ALS+dementia) Ubiquitin-negative Tau-negative  Dementia lacking distinctive histology  Miscellaneous specific types Tau-positive  Pick disease  Corticobasal degeneration  PSP  FTDP-17 FRONTOTEMPORAL DEMENTIAS Behavioral / personality changes Progressive nonfluent aphasia, semantic dementia

Progressive supranuclear palsy without PSP PSP with “PSP” All PSP as defined by tau + We probably need a new name….

PSP illustrates two general principles of neurodegenerative disease  Importance of protein aggregation -Characteristic inclusions / deposits in different diseases -Current basis for histologic classification / diagnosis throughout the neurodegenerative diseases  “Neurodegenerative” diseases involve glia, too You see what you look for!